These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Induction of mucosal immunity through systemic immunization: Phantom or reality? Su F; Patel GB; Hu S; Chen W Hum Vaccin Immunother; 2016 Apr; 12(4):1070-9. PubMed ID: 26752023 [TBL] [Abstract][Full Text] [Related]
5. Nanotechnology solutions for mucosal immunization. Chadwick S; Kriegel C; Amiji M Adv Drug Deliv Rev; 2010 Mar; 62(4-5):394-407. PubMed ID: 19931581 [TBL] [Abstract][Full Text] [Related]
6. B cell and T cell immunity in the female genital tract: potential of distinct mucosal routes of vaccination and role of tissue-associated dendritic cells and natural killer cells. Anjuère F; Bekri S; Bihl F; Braud VM; Cuburu N; Czerkinsky C; Hervouet C; Luci C Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():117-22. PubMed ID: 22882377 [TBL] [Abstract][Full Text] [Related]
8. Recent advances in mucosal vaccine development. Chen H J Control Release; 2000 Jul; 67(2-3):117-28. PubMed ID: 10825547 [TBL] [Abstract][Full Text] [Related]
9. Controlled release of antibodies for long-term topical passive immunoprotection of female mice against genital herpes. Sherwood JK; Zeitlin L; Whaley KJ; Cone RA; Saltzman M Nat Biotechnol; 1996 Apr; 14(4):468-71. PubMed ID: 9630921 [TBL] [Abstract][Full Text] [Related]
10. Mucosal delivery of vaccines in domestic animals. Gerdts V; Mutwiri GK; Tikoo SK; Babiuk LA Vet Res; 2006; 37(3):487-510. PubMed ID: 16611560 [TBL] [Abstract][Full Text] [Related]
11. Exploiting mucosal surfaces for the development of mucosal vaccines. Meeusen EN Vaccine; 2011 Nov; 29(47):8506-11. PubMed ID: 21945494 [TBL] [Abstract][Full Text] [Related]
13. Biodegradable polymeric microsphere-based vaccines and their applications in infectious diseases. Lin CY; Lin SJ; Yang YC; Wang DY; Cheng HF; Yeh MK Hum Vaccin Immunother; 2015; 11(3):650-6. PubMed ID: 25839217 [TBL] [Abstract][Full Text] [Related]
15. Novel approaches to pediatric vaccine delivery. O'Hagan DT; Rappuoli R Adv Drug Deliv Rev; 2006 Apr; 58(1):29-51. PubMed ID: 16480788 [TBL] [Abstract][Full Text] [Related]
16. Biodegradable polymer microspheres as vaccine adjuvants and delivery systems. Gupta RK; Chang AC; Siber GR Dev Biol Stand; 1998; 92():63-78. PubMed ID: 9554260 [TBL] [Abstract][Full Text] [Related]
17. Mucosal responses to parenteral and mucosal vaccines. Kaul D; Ogra PL Dev Biol Stand; 1998; 95():141-6. PubMed ID: 9855424 [TBL] [Abstract][Full Text] [Related]
18. Mucosal delivery routes for optimal immunization: targeting immunity to the right tissues. Czerkinsky C; Holmgren J Curr Top Microbiol Immunol; 2012; 354():1-18. PubMed ID: 21053117 [TBL] [Abstract][Full Text] [Related]
19. Advances in transcutaneous vaccine delivery: do all ways lead to Rome? Bal SM; Ding Z; van Riet E; Jiskoot W; Bouwstra JA J Control Release; 2010 Dec; 148(3):266-82. PubMed ID: 20869998 [TBL] [Abstract][Full Text] [Related]